A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]).
Kuntz
Richard E
RE
Brigham and Women's Hospital, Boston, Massachusetts 02215, USA. Rkuntz@partners.org
Baim
Donald S
DS
Cohen
David J
DJ
Popma
Jeffrey J
JJ
Carrozza
Joseph P
JP
Sharma
Samin
S
McCormick
Daniel J
DJ
Schmidt
Dwayne A
DA
Lansky
Alexandra J
AJ
Ho
Kalon K L
KK
Dandreo
Kimberly J
KJ
Setum
Cindy M
CM
Ramee
Stephen R
SR
D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D018572:Disease-Free Survival; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D018056:Hemorheology; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D008875:Middle Aged; D017131:Thrombectomy / Q000295:instrumentation / Q000379:methods; D016896:Treatment Outcome; D014481:United States; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D014568:Urokinase-Type Plasminogen Activator